State Street Corp Purchases 54,700 Shares of Alpha Teknova, Inc. (NASDAQ:TKNO)

State Street Corp boosted its position in Alpha Teknova, Inc. (NASDAQ:TKNO) by 249.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 76,645 shares of the company’s stock after acquiring an additional 54,700 shares during the period. State Street Corp owned 0.14% of Alpha Teknova worth $371,000 at the end of the most recent quarter.

Separately, Roubaix Capital LLC bought a new position in shares of Alpha Teknova in the 3rd quarter valued at about $2,015,000. 13.81% of the stock is owned by hedge funds and other institutional investors.

Alpha Teknova Stock Up 4.7 %

Shares of NASDAQ:TKNO opened at $8.71 on Friday. The company has a 50 day moving average of $7.55 and a 200-day moving average of $5.15. Alpha Teknova, Inc. has a one year low of $1.15 and a one year high of $9.72. The stock has a market cap of $464.31 million, a price-to-earnings ratio of -11.77 and a beta of 0.37. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.73 and a quick ratio of 3.94.

Alpha Teknova (NASDAQ:TKNO) last released its earnings results on Thursday, November 7th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.04). Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The business had revenue of $9.58 million for the quarter, compared to analyst estimates of $9.30 million. During the same period in the prior year, the firm posted ($0.34) EPS. On average, sell-side analysts forecast that Alpha Teknova, Inc. will post -0.58 earnings per share for the current year.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.